Exploring adaptations to the modified shuttle walking test

BMJ Open

Volumn 3, Issue 5, 2013, Pages

  Woolf May, Kate ^a   Meadows, Steve ^b  

^a CANTERBURY CHRIST CHURCH UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF KENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EXERCISE; FUNCTIONAL ASSESSMENT; HEART INFARCTION; HEART RATE; HUMAN; LUNG GAS EXCHANGE; MALE; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; SHUTTLE WALKING TEST; WALKING SPEED;

EID: 84878391106     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002821     Document Type: Article

References (42)

1. Scottish Intercollegiate Guidelines Network (SIGN). Cardiac rehabilitation: a national clinical guideline. Guideline 57. Edinburgh: SIGN, 2002. http://www.sign.ac.uk/pdf/sign57.pdf
2. The Association of Chartered Physiotherapists in Cardiac Rehabilitation (ACPICR). Standards for physical activity and exercise in the cardiac population. 2009. http://acpicr.com/publications
3. British Association of Cardiac Prevention and Rehabilitation (BACPR). The BACPR standards and core components for cardiovascular disease prevention and rehabilitation. 2nd edn. London: BACPR, 2012.
4. American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). Guidelines for cardiac rehabilitation & secondary prevention programs. 4th edn. Illinois: Human Kinetics, 2004.
5. Blair SN, James PED, Kampert B, et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA 1996;276:205-10. (Pubitemid 26235064)
6. Farrell SW, Kampert JB, Kohl HW, et al. Influences of cardiorespiratory fitness levels and other predictors on cardiovascular disease mortality in men. Med Sci Sports Exerc 1998;30:899-905. (Pubitemid 28262379)
7. Myers J, Goebbels U, Dzeikan G, et al. Exercise training and cardiac remodelling in patients with reduced ventricular function: one year follow-up with magnetic resonance imaging. Am Heart J 2000;139:252-61. (Pubitemid 30090802)
8. Singh SL, Morgan MD, Scott S, et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992;47:1019-24. (Pubitemid 23011018)
9. Tobin D, Thow MK. The 10 m shuttle walk test with Holter monitoring: an objective outcome measure for cardiac rehabilitation. Coron Health Care 1999;3:3-17.
10. Arnott AS. Assessment of functional capacity in cardiac rehabilitation: reproducibility of a 10-m shuttle walk test. Coron Health Care 1997;1:30-6.
11. Fowler SJ, Singh SJ, Revill S. Reproducibility and validity of the incremental shuttle walking test in patients following coronary artery bypass surgery. Physiotherapy 2005;91:22-7. (Pubitemid 44296118)
12. Payne GE, Skehan JD. Shuttle walking test: a new approach for evaluating patients with pacemakers. Heart 1996;75:414-18. (Pubitemid 26155579)
13. Green DJ, Watts K, Rankin S, et al. A comparison of the shuttle and 6 minute walking tests with measured peak oxygen consumption in patients with heart failure. JSMS 2001;4:292-300. (Pubitemid 32970970)
14. Morales FJ, Montemayor T, Martinez A. Shuttle versus six-minute walk test in the prediction of outcome in chronic heart failure. Int J Cardiol 2000;76:101-5.
15. Keell SD, Chambers JS, Francis DP, et al. Shuttle-walk test to assess chronic heart failure. Lancet 1998;352:705. (Pubitemid 28398710)
16. Woolf-May K, Ferrett D. Metabolic equivalents during the 10-metre shuttle-walking test for post-MI patients. BJSM 2008;42:36-41. (Pubitemid 351158207)
17. Young ME, Razeghi P, Cedars AM, et al. Intrinsic diurnal variations in cardiac metabolism and contractile function. Circ Res 2001;89:1199-208. (Pubitemid 34627879)
18. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377.
19. Davies LC, Wensel R, Georgiadou P, et al. Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. Eur Heart J 2006;27:684-90.
20. Keteyian SJ, Clinton A, Brawner MS, et al. Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Am Heart J 2008;156:292-300.
21. World Health Organisation (WHO). Global database on body mass index. http://apps.who.int/bmi/index.jsp?introPage=intro-3.html (accessed Nov 2012).
22. Wasserman K, Mcllroy MB. Detecting the threshold of anaerobic metabolism in cardiac patients during exercise. Am J Cardiol 1964;14:844-52.
23. Solberg G, Robstad B, Skjonsberg OH, et al. Respiratory gas exchange indices for estimating the anerobic threshold. Sport Sci Med 2005;4:29-36. (Pubitemid 43580564)
24. Fortini A, Bonechi F, Taddei T, et al. Anaerobic threshold in patients with exercise-induced myocardial ischemia. Circulation 1991;83:11150-3.
25. Roberts MJ, Sullivan M, Froelicher VF, et al. Predicting oxygen uptake from treadmill testing in normal subjects and coronary artery disease patients. Am Heart J 1984;108:1454-60. (Pubitemid 15075897)
26. National Institute of Clinical Excellence (NICE). Post myocardial infarction: secondary prevention in primary and secondary care for patients following a myocardial infarction. Full Guidelines CG48, 2007. http://www.nice.org.uk/nicemedia/live/11008/30493/30493.pdf
27. 2 to steady state of submaximal exercise with beta-blockade. Eur J Appl Physiol 1983;52:107-10. (Pubitemid 14245209)
28. Reents S. Sport and exercise pharmacology. Champaign, Illinois: Human Kinetics, 2000.
29. Hall PE, Kendall MJ, Smith SR. Beta blocker and fatigue. J Clin HosPharm 1984;9:283-91.
30. Eston RG, Connolly D. The use of ratings of perceived exertion for exercise prescription in patients receiving β-blocker therapy. Sports Med 1996;21:176-90. (Pubitemid 26092728)
31. Head A, Maxwell S, Kendall MJ. Exercise metabolism in healthy volunteers taking celiprolol, atenolol, and placebo. BJSM 1997;31:120-5. (Pubitemid 27277648)
32. Lamont LS, Romito RC, Finkelhor RS, et al. Beta1-adrenoreceptors regulate resting metabolic rate. Med Sci Sports Exerc 1997;29:769-74. (Pubitemid 27290736)
33. Moosmann B, Behl C. Selenoprotein synthesis and side effects of statins. Lancet 2004;363:892-4. (Pubitemid 38368841)
34. Deacon SP. The effect of atenolol and propranolol upon lipolysis. Brit J Clin Pharmacol 1978;5:123-5. (Pubitemid 8263488)
35. Karlsson J. Metabolic adaptation to exercise: a review of potential beta-adrenoceptor antagonistic effects. Am J Cardiol 1985;55:48D-58D. (Pubitemid 15099994)
36. Davies CT, Sargeant AJ. The effects of atropine and practolol on the perception of exertion during treadmill exercise. Ergonomics 1979;22:1141-6. (Pubitemid 10167143)
37. Sjoberg H, Frankenhaeuser M, Bjurstedt H. Interactions between heart rate, psychomotor performance and perceived effort during physical work as influenced by beta-andrenergic blockade. Biol Psychol 1979;8:31-43. (Pubitemid 9162124)
38. van Herwarden CL, Binkhorst RA, Fennis JF, et al. Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients. Br Heart J 1979;41:99-105. (Pubitemid 9106750)
39. Lewis ME, Newall JN, Townend SL, et al. Incremental shuttle walk test in the assessment of patients for heart transplantation. Heart 2001;86:183-7. (Pubitemid 32983486)
40. Green DJ, Watts K, Rankin S, et al. A comparison of the shuttle and 6 minute walking tests with measured peak oxygen consumption in patients with heart failure. J Sci Med Sport 2001;4:292-300. (Pubitemid 32970970)
41. Singh SL, Morgan MD, Hardman A, et al. Comparison of oxygen uptake during a conventional treadmill test and the shuttle walk test in chronic airflow limitation. Eur Resp J 1994;7:2016-20. (Pubitemid 24366294)
42. Bland JM, Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10. (Pubitemid 16134762)